Zurich, Switzerland

Oliver Flögel


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Oliver Flögel: Innovator in Pharmaceutical Chemistry

Introduction

Oliver Flögel is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 2 patents, Flögel's work focuses on creating intermediates that are essential for the synthesis of complex pharmaceutical agents.

Latest Patents

Flögel's latest patents include the invention of substituted 2-[3-(1-methyl-piperidin-4-yl)-propylamino]-pyrimidine-5-carboxylic acids and amides. This invention relates to certain intermediates that are useful in the preparation of benzoimidazol-2-yl pyrimidines. The processes he has developed for preparing these compounds are crucial for advancing pharmaceutical research and development.

Career Highlights

Flögel has established a successful career at Janssen Pharmaceutica NV, where he has been instrumental in various research projects. His expertise in pharmaceutical chemistry has allowed him to contribute to the development of innovative solutions in drug formulation and synthesis.

Collaborations

Throughout his career, Flögel has collaborated with talented professionals in the field, including Diego Broggini and Matteo Conza. These collaborations have enhanced the scope and impact of his research, leading to advancements in pharmaceutical applications.

Conclusion

Oliver Flögel's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…